Twelve questions, and three answers that should end the conversation entirely. The useful framing is that you are not buying a medication, you are buying a clinical service that includes one, and the differences between services are mostly in the parts that are not the drug. Those differences become visible when something goes wrong, which is after you have paid.<\/p>\n
Ask these before you commit. A service that answers them readily is telling you something, and so is one that does not.<\/p>\n
Take these as disqualifying rather than as concerns to weigh.<\/p>\n
No prescriber involvement, or a prescription without any clinical review.<\/strong> If nobody is reviewing your history before writing a prescription, the thing you are buying is not medical care.<\/p>\n They will not tell you which pharmacy prepares your medication.<\/strong> For a compounded preparation this is the single most important question, because these products are not FDA-approved and the quality controls sit with the preparing pharmacy rather than with a premarket review process. An unwillingness to name it is the answer.<\/p>\n No prescription required at all.<\/strong> This is not a telehealth service. Products sold this way carry unknown identity, unknown concentration, and unknown sterility, and the documented harm comes from concentration errors rather than anything exotic.<\/p>\n On the clinical side:<\/strong><\/p>\n Question three is worth asking specifically. Over a titration period that runs several months, a service that charges per consultation can cost considerably more than its headline price.<\/p>\n On the medication:<\/strong><\/p>\n Question eight matters because concentration differs between preparations, and drawing a familiar volume from an unfamiliar vial is a documented route to a dosing error. Our guide on verifying that a compounding pharmacy is safe and legitimate<\/a> covers what good practice looks like.<\/p>\n On the commercial terms:<\/strong><\/p>\n Question ten catches introductory pricing, which is the most common reason a service turns out to cost more than expected. Our guide on Ozempic cost and affordable alternatives<\/a> covers the wider pricing picture, including manufacturer programmes for approved products that a cash-pay service will not mention.<\/p>\n Worth understanding before you sign anything.<\/p>\n Large-scale compounding of these medications grew during a period when they were in shortage. Those shortages were declared resolved, and what remains is a narrower, patient-specific route requiring documented clinical need that an approved product cannot meet. Regulators have also acted on how these products are marketed.<\/p>\n The practical implication for you is not that compounded preparations are unavailable. It is that a service presenting a compounded product as simply a cheaper version of an approved one is describing a situation that no longer holds, and that is worth noticing about how they operate generally. Our guide on accessing semaglutide without insurance<\/a> covers how access works now.<\/p>\n Ask directly whether your prescription would be for an approved product or a compounded preparation, and if compounded, on what basis.<\/p>\n Have you exhausted coverage?<\/strong> Cash-pay services do not typically help you appeal a denial or apply for a manufacturer programme, because those routes do not involve them. If you have not tried, do that first.<\/p>\n Does your regular doctor know?<\/strong> If your GLP-1 comes from a telehealth service and the rest of your care sits elsewhere, neither has the full picture unless you supply it. That gap is the most common structural problem in this model, and it is worth deciding now how you will close it.<\/p>\n Consider this scenario: someone signs up on an advertised monthly price, does well, and reaches their maintenance dose five months later. The price at that dose is nearly double, dose adjustment consultations were charged each time, and when a shipment arrived warm nobody would replace it. None of that was concealed. None of it was asked about either.<\/p>\n Do not choose on the advertised price.<\/strong> It is the least informative number available.<\/p>\n Do not skip the pharmacy question<\/strong> because the website looks professional.<\/p>\n Do not accept a prescription written without a history review<\/strong>, however convenient.<\/p>\n Do not pay for a long prepaid period<\/strong> before you know how the service behaves when something goes wrong.<\/p>\n You are buying a clinical service, and the differences live in provider access, whether dose changes are included, who prepares the medication, and what happens when a delivery fails. Price it at your maintenance dose and annually. Treat three answers as disqualifying: no clinical review, no named pharmacy, and no prescription required. And check your coverage options before paying cash at all.<\/p>\nThe twelve questions<\/h2>\n
\n
\n
\n
What the compounded question turns on now<\/h2>\n
Two questions about you, not them<\/h2>\n
What not to do<\/h2>\n
The short version<\/h2>\n